planet: pembrolizumab with lanreotide depot for advanced gep-nets
Published 3 years ago • 140 plays • Length 7:38Download video MP4
Download video MP3
Similar videos
-
7:02
paul's story with gep-nets | somatuline® depot (lanreotide)
-
1:47
maryann’s diagnosis with gep-nets | somatuline® depot (lanreotide)
-
7:29
ann's story with gep-nets | somatuline® depot (lanreotide)
-
1:00
crystal’s story with pnets | somatuline® depot (lanreotide)
-
9:02
how to administer a somatuline depot (lanreotide) injection 120 mg
-
2:45
efficacy of lanreotide to treat neuroendocrine tumors
-
3:04
unmet needs in nets
-
1:33
ipsen's lanreotide depot - current and future indications
-
12:21
watchful learning & surveillance of nets - emily bergsland
-
5:56
follow-up care for neuroendocrine tumors
-
1:13
why pfs is a good outcome measure for neuroendocrine tumors
-
1:17
dr. kunz on the impact of lanreotide’s approval for neuroendocrine tumors
-
1:14
dr. phan on clarinet subgroup analysis
-
1:17
borealis-1™: phase 2 trial of gemcitabine/cisplatin plus apatorsen in advanced bladder cancer
-
0:41
netrf session 4 finding the causes of multifocal intestinal nets
-
4:30
pilot study of pembrolizumab plus exemestane/leuprolide for premenopausal metastatic breast cancer
-
1:56
safety profile of lanreotide
-
3:06
living with nets: the home of neuroendocrine tumours (nets) information and support
-
1:15
netrf session 5 epigenietic regulators of intestinal endocrine cells and carcinoid tumors